Synchron Announces Positive Results from U.S. COMMAND Study of Endovascular Brain-Computer Interface
In a major step forward for next-generation implantable BCI devices, Synchron has just announced positive safety results from their COMMAND clinical trial, reporting no serious adverse events in brain/vasculature of the 6 patients enrolled over 12 months! Impressively, surgeries had a median deployment time of 20 minutes, demonstrating a major advantage of the Stentrode technology. […]